京新药业：上半年地达西尼已累计实现医院覆盖数量达1500多家

Core Insights - Jingxin Pharmaceutical has achieved hospital coverage of over 1,500 for its drug Didasanib in the first half of the year, indicating a strong market presence and ongoing efforts to enhance patient accessibility [2] Company Summary - The company is actively promoting the hospital admission of Didasanib, which reflects its commitment to improving patient access to this medication [2]